Dividend Calculator Dividend Returns Comparison Dividend Calendar

My Experts Top Analysts Top Financial Bloggers Top-Performing Corporate Insiders Top Hedge Fund Managers Top Research Firms Top Individual Investors

Education

Personal Finance How To Use TipRanks TipRanks Labs Webinar Center Glossary FAQs

About Us

About TipRanks Contact Us Careers Reviews Mobile APP

Working with TipRanks

Enterprise Solutions Top Online Brokers Become an Affiliate

News Trending Portfolio

TOOLS

Top Smart Score Stocks

STOCKS

Best High Yield Dividend Stocks

Dividend Aristocrats

Dividend Stock Comparison

New

Dividend Calculator

Dividend Returns Comparison

Dividend Calendar

Top Analysts

Top Financial Bloggers

Top-Performing Corporate Insiders

Top Hedge Fund Managers

Top Research Firms

Top Individual Investors

News

Portfolio

Personal Finance Center

Mortgages

Loans

Investing & Retirement

Spending & Savings

Calculators

Compound Interest Calculator

Student Loan Calculator

401k Retirement Calculator

Education

About Us

Working with TipRanks

Enterprise Solutions

Top Online Brokers

Become an Affiliate

iTeos Therapeutics (ITOS)

NASDAQ:ITOS

ITOS

iTeos Therapeutics

RESEARCH TOOLS

Top Smart Score Stocks

Stock Screener

reports

Holding ITOS?

Track your performance easily

Link Broker

iTeos Therapeutics (ITOS) Stock News & Sentiment

171 Followers

iTeos Therapeutics Reports Positive Phase 2 Cancer Trial Results

Premium

Company Announcements

iTeos Therapeutics Reports Positive Phase 2 Cancer Trial Results

24d ago

ITOS

Premium

Market News

iTeos Therapeutics (NASDAQ:ITOS): Harnessing the Power of Immunotherapy

5M ago

ITOS

Down More Than 50%: 2 ‘Strong Buy’ Stocks That Are Too Cheap to Ignore

Premium

Stock Analysis & Ideas

Down More Than 50%: 2 ‘Strong Buy’ Stocks That Are Too Cheap to Ignore

2y ago

GHRS

ITOS

ITOS News on the Web

2024-09-22

The One-Minute Market Report - Sunday, Sept. 22

TalkMarkets

Neutral

2024-09-16

iTeos Therapeutics (ITOS) Receives a Buy from Piper Sandler

TipRanks News

Bullish

2024-09-16

ESMO 2024: TIGIT race tightens with first look at GSK/iTeos’s TIGIT in NSCLC

Pharmaceutical Technology

Neutral

2024-09-14

Buy Rating Affirmed for iTeos Therapeutics Amid Promising Lung-201 Study Outcomes

TipRanks News

Bullish

2024-09-14

TIGIT drug from iTeos shrinks lung tumors in trial

BioPharma Dive

Neutral

2024-08-28

iTeos to Participate in Upcoming Investor Conferences

Yahoo Finance

Neutral

2024-08-25

We're Keeping An Eye On iTeos Therapeutics' Cash Burn Rate

Yahoo Finance

Neutral

2024-08-20

iTeos Therapeutics Announces Late-Breaking Oral Presentation of Phase 2 GALAXIES Lung-201 Interim Data at the European Society for Medical Oncology Congress 2024

Yahoo Finance

Neutral

News Score - Last 7 Days

Not enough data to generate a sentiment score

Media Buzz

This Week0 articles

Weekly Average0 articles

News Sentiment

Currently, no data available

See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is ITOS’s Media Buzz Sentiment?

Currently, no data Available

What is ITOS’s weekly average amount of articles?

Currently, no data Available

What is ITOS’s News Sentiment?

Currently, no data Available

Healthcare Stocks that are Trending in the News

PRCTPROCEPT BioRobotics

SRRKScholar Rock Holding

CLSDClearside Biomedical

ACCDAccolade

OMCLOmnicell

Showing the stocks with the most bullish news sentiment over the past week

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing